Highly Bioavailable CoQ10 Formula. Supports Healthy Cardiovascular Function with Extend-Rx Technology.
Pharmatech, Ltd., a product development and research company in Belize, undertook a study to compare the bioavailability of various delivery forms of Co Q10 that are presently being sold. Included in this study was a proprietary CoQ10 product from Hi-Tech Pharmaceuticals that incorporates Extend-Rx technology. This was compared to CoQ10 products in softgel capsules (in an oil base), powder-filled hardshell capsules and powder-based tablets. Test subjects were given a daily dose of 100mg for four weeks. The baseline plasma CoQ10 values for all subjects in all four groups were statistically similar (0.52 - 0.55 mcg/ml). After four weeks, the avarage values wer 1.4mcg/ml for the subjects who ingested the softgel capsules, 1.65mcg/ml for the powder-filled hardshell capsule group, and 1.62mcg/ml for the powder-based tablets group. The group that ingested the Hi-Tech CoQ10 product with Extend-Rx technology demonstrated an average value of 4.15mcg/ml. This data supports that Extend-Rx technology increases the bioavailability of CoQ10, and that the Hi-Tech product is vastly superior to other forms of Co Q10 products available.